Navigation Links
Voices Against Brain Cancer Comments on Recent Discovery in Ongoing Brain Cancer Research
Date:6/25/2013

New York, NY (PRWEB) June 25, 2013

On June 25, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on the recent discovery of a combination of viruses that has proven to be effective against the deadliest forms of brain tumors.

According to an article on ScienceDaily.com, a combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most common and deadliest malignant brain tumor. This was reported by research performed by the Moffitt Cancer Center.

Peter A. Forsyth, M.D., of Moffitt’s Neuro-Oncology Program, says the combination “has been shown to infect and kill both brain cancer stem cells and differentiated compartments of glioblastoma multiforme.” This finding means that current barriers to treating the disease may be overcome. For example, some brain cancer patients experience drug resistance to existing therapies, which has become an obstacle in treatment. Forsyth says, “Oncolytic viruses that infect and break down cancer cells offer promising possibilities for overcoming resistance to targeted therapies.”

The authors of the study explain that the combination of viruses have the potential to start a “multipronged attack” on a tumor, with the possibility of killing cancer cells directly through viral infection and inducing the immune system to attack the tumor. There have been several oncolytic viruses that have been tested and show promise against malignant gliomas.

Forsyth says, “We found that myxoma virus combined with rapamycin is a potentially useful combination. The idea that cancer cells can be killed by a harmless virus is an exciting prospect for therapy.”

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, sees this as a huge breakthrough for brain cancer treatment. “This discovery is obviously in its initial stages of testing but it shows promise for finding an actual cure in the somewhat near future. Any progress is good progress and we can’t commend all scientists involved in brain cancer research enough for all that they do to find an end to this deadly disease.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations
#####

Read the full story at http://www.prweb.com/releases/braincancer/research/prweb10864746.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
2. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
3. Voices Against Brain Cancer Commends Father of Nine for Running Marathons Despite Diagnosis
4. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
5. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
6. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
7. Voices Against Brain Cancer Commends Family for their Ongoing Efforts to Spread Brain Cancer Awareness
8. Avatar therapy helps silence voices in schizophrenia
9. Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells
10. Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle
11. Voices Against Brain Cancer Commends Mother for the Way She Honors Her Daughter’s Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 ... ... non-profit medical society dedicated to advancing the science and clinical practice of ... its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a leading ... Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up ... association with efforts by the American College of Surgeons, U.S. Department of Defense, ...
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... director. Mr. Still was selected through a careful months-long search by the RBMA Board ... to our members, has been a part of building the RBMA since 1992,” said ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm ... its corporate headquarters to a new, more expansive office space in order to ... Qualidigm purchased a distressed office building in Wethersfield, Conn. located at 936 Silas ...
(Date:3/28/2017)... Billerica, MA (PRWEB) , ... March 28, 2017 ... ... instrument for direct measurement of corrosive ions found in power plant water and ... plant components such as turbines and boilers, leading to extensive maintenance and unplanned ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... -- The global surgical sealants and ... USD 4.5 billion by 2025, according to a new ... injured tissues post operation is a major step to ... 3% to 15% of cases and are considered as ... of postoperative deaths in patients. Surgical sealants and adhesives ...
(Date:3/27/2017)... -- Summary This report provides all ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/27/2017)... -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the "Company") ... common stock in an underwritten public offering under an ... and Exchange Commission (the "SEC"). The offering is subject ... no assurance as to whether or when the offering ... or terms of the offering. Cryoport also expects to ...
Breaking Medicine Technology: